NovoCure Ltd DEF 14A: Executive Compensation & Equity Awards
Ticker: NVCR · Form: DEF 14A · Filed: Apr 21, 2025 · CIK: 1645113
| Field | Detail |
|---|---|
| Company | Novocure Ltd (NVCR) |
| Form Type | DEF 14A |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: DEF 14A, executive-compensation, equity-awards, corporate-governance
TL;DR
NovoCure DEF 14A out: Check exec pay & equity awards for 2024. #CorpGov
AI Summary
NovoCure Ltd filed a DEF 14A on April 21, 2025, for the fiscal year ending December 31, 2024. The filing pertains to the company's annual meeting and includes information on executive compensation and equity awards granted in covered years. Specific financial figures for 2024, 2023, 2022, 2021, and 2020 are referenced in relation to these awards.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and equity awards, impacting corporate governance and potential shareholder value.
Risk Assessment
Risk Level: medium — DEF 14A filings often contain information about executive compensation and corporate governance that can influence investor sentiment and stock performance.
Key Numbers
- 2024 — Fiscal Year (Reporting period for equity awards)
- 2023 — Fiscal Year (Reporting period for equity awards)
- 2022 — Fiscal Year (Reporting period for equity awards)
- 2021 — Fiscal Year (Reporting period for equity awards)
- 2020 — Fiscal Year (Reporting period for equity awards)
Key Players & Entities
- NovoCure Ltd (company) — Filer of the DEF 14A
- 2024-12-31 (date) — Fiscal year end
- 20250421 (date) — Filing date
FAQ
What is the primary purpose of this DEF 14A filing for NovoCure Ltd?
The primary purpose is to provide information to shareholders regarding the annual meeting, including details on executive compensation and equity awards for the fiscal year ending December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
The filing was submitted on April 21, 2025.
What specific financial data is referenced in relation to equity awards?
The filing references financial data for the fiscal years 2024, 2023, 2022, 2021, and 2020 in relation to equity awards.
What is NovoCure Ltd's Standard Industrial Classification (SIC) code?
NovoCure Ltd's SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What is the filing date as of which the information in this report is current?
The filing is as of April 21, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 21, 2025 regarding NovoCure Ltd (NVCR).